Especially, we could not confirm any correlation of in vivo anti-tumor reactivity to dissociation half-lives of TCRs from their p-MHC complexes (12, 64) as well as functional avidity of TCRs toward the cognate MHC-peptide complexes (9). The gene discussed is HLA-C; the disease is neoplasm.